• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics

Jef Feeley

Stay informed with Jef Feeley’s coverage and analysis for Fortune.

    Page 4 of 4

  • A shareholder lawsuit alleges that Boeing directors ignored red flags during the  production of the 737 Max 8 and didn’t respond promptly to crashes in Ethiopia and Indonesia.Tech

    Boeing Directors Sued for Rushing 737 Max 8 to Market

    By Jef Feeley and Bloomberg
  • PURDUE PHARMA, STAMFORD, CT, UNITED STATES - 2019/09/12: Members of P.A.I.N. (Prescription Addiction Intervention Now) and Truth Pharm staged a protest on September 12, 2019 outside Purdue Pharma headquarters in Stamford, over their recent controversial opioid settlement. Participants dropped hundreds prescription bottles of OxyContin while holding tombstones with the names of opioids casualties and banners reading "Shame on Sackler" and "200 Dead Each Day". (Photo by Erik McGregor/LightRocket via Getty Images)Health

    Purdue Pharma’s $10 Billion Bankruptcy Plan to Settle Opioid Epidemic Claims Heads to Court

    By Jef Feeley, Steven Church, and others
  • Opioid pain killersHealth

    J&J, Walgreens, and Others Must Face Lawsuits Claiming Conspiracy to Push Opioids, Judge Rules

    By Jef Feeley and Bloomberg
  • Purdue sign

    Sacklers to Remain Billionaire Family If Purdue Settles Opioid Lawsuits

    By Tom Maloney, Jef Feeley, and others
  • Purdue Pharma bankruptcyHealth

    Sackler Family Backs $11B Settlement of Opioid Lawsuits That Would See Purdue Pharma File for Bankruptcy

    By Jef Feeley, Riley Griffin, and others
  • A judge has ordered the company to pay $572 million in connection with the opioid crisis in OklahomaHealth

    J&J Shares Rise After Lower Than Expected Award for Company’s Part in Opioid Crisis

    By Jef Feeley, Riley Griffin, and others
  • Roundup weedkiller with rakeInternational

    Bayer Wants to Settle All Roundup-Related Cancer Claims for $8 Billion

    By Tim Loh, Joel Rosenblatt, and others
  • A used syringe in the dirt.

    Johnson & Johnson Accused of Dodging Liability for Its Alleged Role in Opioid Epidemic

    By Jef Feeley and Bloomberg
  • Parents Of Overdose Victims Protest OxyContin Maker At Court Hearing

    Purdue Pharma to Settle Oklahoma Opioid Lawsuit for $270 Million

    By Jef Feeley and Bloomberg
    Rankings
    • 100 Best Companies
    • Fortune 500
    • Global 500
    • Fortune 500 Europe
    • Most Powerful Women
    • Future 50
    • World’s Most Admired Companies
    • See All Rankings
    Sections
    • Finance
    • Leadership
    • Success
    • Tech
    • Asia
    • Europe
    • Environment
    • Fortune Crypto
    • Health
    • Retail
    • Lifestyle
    • Politics
    • Newsletters
    • Magazine
    • Features
    • Commentary
    • MPW
    • CEO Initiative
    • Conferences
    • Personal Finance
    • Education
    Customer Support
    • Frequently Asked Questions
    • Customer Service Portal
    • Privacy Policy
    • Terms of Use
    • Single Issues for Purchase
    • International Print
    Commercial Services
    • Advertising
    • Fortune Brand Studio
    • Fortune Analytics
    • Fortune Conferences
    • Business Development
    About Us
    • About Us
    • Editorial Calendar
    • Press Center
    • Work at Fortune
    • Diversity and Inclusion
    • Terms and Conditions
    • Site Map

    © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.